Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase
- PMID: 1433175
- DOI: 10.1021/jm00098a008
Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase
Abstract
In the preceding paper, analogs of chlorpropamide with an OMe substituent on the sulfonamide nitrogen were shown to inhibit aldehyde dehydrogenase (AlDH), and it was postulated that these compounds were bioactivated by O-demethylation to release nitroxyl (HN = O, nitrosyl hydride), which is an inhibitor of AlDH. Further evidence for the production of nitroxyl from compounds with O-acyl instead of OMe on the sulfonamide nitrogen is now presented. Thus, nitrous oxide (N2O), the end product of nitroxyl dimerization and disproportionation, was found to be generated on alkaline or enzymatic hydrolysis of N,O-diacylated N-hydroxyarylsulfonamides. Since the latter compounds strongly inhibit yeast AlDH in vitro after bioactivation by an esterase intrinsic to this enzyme, nitroxyl generated from these compounds must be the common intermediate that inhibits AlDH.
Similar articles
-
Prodrugs of nitroxyl and nitrosobenzene as cascade latentiated inhibitors of aldehyde dehydrogenase.J Med Chem. 1998 Jul 16;41(15):2903-9. doi: 10.1021/jm980200+. J Med Chem. 1998. PMID: 9667978
-
An N-hydroxylated derivative of cyanamide that inhibits yeast aldehyde dehydrogenase.Alcohol. 1992 Sep-Oct;9(5):349-53. doi: 10.1016/0741-8329(92)90031-5. Alcohol. 1992. PMID: 1418657
-
Prodrugs of nitroxyl as potential aldehyde dehydrogenase inhibitors vis-a-vis vascular smooth muscle relaxants.J Med Chem. 1995 May 26;38(11):1865-71. doi: 10.1021/jm00011a005. J Med Chem. 1995. PMID: 7783118
-
N-hydroxybenzenecarboximidic acid derivatives: a new class of nitroxyl-generating prodrugs.Nitric Oxide. 2001 Jun;5(3):278-87. doi: 10.1006/niox.2001.0349. Nitric Oxide. 2001. PMID: 11384201
-
Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics.Trends Pharmacol Sci. 2019 Oct;40(10):774-789. doi: 10.1016/j.tips.2019.08.002. Epub 2019 Sep 9. Trends Pharmacol Sci. 2019. PMID: 31515079 Review.
Cited by
-
Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.Oxid Med Cell Longev. 2016;2016:4867124. doi: 10.1155/2016/4867124. Epub 2015 Dec 7. Oxid Med Cell Longev. 2016. Retraction in: Oxid Med Cell Longev. 2016;2016:4018417. doi: 10.1155/2016/4018417. PMID: 26770654 Free PMC article. Retracted. Review.
-
Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class.J Am Chem Soc. 2010 Nov 24;132(46):16526-32. doi: 10.1021/ja106552p. Epub 2010 Oct 29. J Am Chem Soc. 2010. PMID: 21033665 Free PMC article.
-
Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method.Mol Cell Proteomics. 2009 May;8(5):887-903. doi: 10.1074/mcp.M800230-MCP200. Epub 2008 Dec 31. Mol Cell Proteomics. 2009. PMID: 19119137 Free PMC article.
-
Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.Pharmacol Rev. 2012 Jul;64(3):520-39. doi: 10.1124/pr.111.005538. Epub 2012 Apr 27. Pharmacol Rev. 2012. PMID: 22544865 Free PMC article. Review.
-
Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects.Inorg Chem. 2010 Jul 19;49(14):6283-92. doi: 10.1021/ic902319d. Inorg Chem. 2010. PMID: 20666387 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Chemical Information